The headquarters of the European Medicines Agency (EMA) in Amsterdam. The body has approved the conditional use of the Pfizer/BioNTech coronavirus vaccine. Photo: EPA-EFE The headquarters of the European Medicines Agency (EMA) in Amsterdam. The body has approved the conditional use of the Pfizer/BioNTech coronavirus vaccine. Photo: EPA-EFE
The headquarters of the European Medicines Agency (EMA) in Amsterdam. The body has approved the conditional use of the Pfizer/BioNTech coronavirus vaccine. Photo: EPA-EFE

Coronavirus pandemic

EU approves Pfizer-BioNTech coronavirus vaccine

  • The European Medicines Agency said the step paves the way for vaccinations to start across the European Union within days
  • The drug regulator had been under pressure from EU governments to authorise the vaccine, as Covid-19 cases surge

Topic |   Coronavirus pandemic
The headquarters of the European Medicines Agency (EMA) in Amsterdam. The body has approved the conditional use of the Pfizer/BioNTech coronavirus vaccine. Photo: EPA-EFE The headquarters of the European Medicines Agency (EMA) in Amsterdam. The body has approved the conditional use of the Pfizer/BioNTech coronavirus vaccine. Photo: EPA-EFE
The headquarters of the European Medicines Agency (EMA) in Amsterdam. The body has approved the conditional use of the Pfizer/BioNTech coronavirus vaccine. Photo: EPA-EFE
READ FULL ARTICLE